|
EP2919766B1 |
26 May, 2021
|
Sustained-Release Dosage Forms Of Ruxolitinib
|
Nov, 2033
|
4
| |
|
EP3070090B1 |
12 Dec, 2018
|
Use Of Salts Of The Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H- Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile
|
Jun, 2028
|
1
| |
|
EP3184526B1 |
03 Oct, 2018
|
Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase Inhibitor
|
NA
|
1
| |
|
EP2671882B1 |
21 Feb, 2018
|
Pyrrolo[2,3-B]Pyridin-4-Yl-Amines And Pyrrolo[2M3-B]Pyrimidin-4-Yl-Amines As Janus Kinase Inhibitors
|
NA
|
1
| |
|
EP3050882B1 |
31 Jan, 2018
|
Piperidin-4-Yl Azetidine Derivatives As Jak1 Inhibitors
|
Mar, 2031
|
1
| |
|
EP2300455B1 |
19 Jul, 2017
|
Salts Of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Yl-Methyl) - Imidazo [1, 2-B] [1, 2, 4] Triazin-2-Yl] Benzamide And Processes Related To Preparing The Same
|
NA
|
1
| |
